Efficacy of urinary trypsin inhibitor in the treatment of rats with severe sepsis and its effects on coagulation and immunity-Reference-Cited by-同舟云学术

Efficacy of urinary trypsin inhibitor in the treatment of rats with severe sepsis and its effects on coagulation and immunity

Published:2022-10-11 Issue: Volume: Page:
ISSN:1738-642X
Container-title:Molecular & Cellular Toxicology
language:en
Short-container-title:Mol. Cell. Toxicol.

Author:

Tang Biao,Yao Jiemin,Wu Shengtian,Zhu Haibin,Li Zhiheng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,General Pharmacology, Toxicology and Pharmaceutics,Toxicology,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13273-022-00303-4.pdf

Reference32 articles.

1. Adamik B, Gozdzik W, Jakubczyk D, Welna M, Kubler A (2017) Coagulation abnormalities identified by thromboelastometry in patients with severe sepsis: the relationship to endotoxemia and mortality. Blood Coagul Fibrinolysis 28:163–170. https://doi.org/10.1097/MBC.0000000000000572

2. Atal SS, Atal S (2016) Ulinastatin–a newer potential therapeutic option for multiple organ dysfunction syndrome. J Basic Clin Physiol Pharmacol 27:91–99

3. Cao Y-Z et al (2012) Protective effect of Ulinastatin against murine models of sepsis: inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol 64:543–547

4. Cao C et al (2018) Ulinastatin mediates suppression of regulatory T cells through TLR4/NF-kappaB signaling pathway in murine sepsis. Int Immunopharmacol 64:411–423. https://doi.org/10.1016/j.intimp.2018.09.025

5. Chen Q et al (2017) Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy chinese volunteers: a randomized, double-blind, placebo-controlled, ascending-dose study. PloS one. https://doi.org/10.1371/journal.pone.0177425)